Towa Pharmaceutical (TWAPF) Expected to Announce Quarterly Earnings on Thursday

Towa Pharmaceutical (OTCMKTS:TWAPF) will likely be announcing its resultson Thursday, May 14th. Analysts expect the company to announce earnings of $0.6790 per share and revenue of $468.8690 million for the quarter.

Towa Pharmaceutical Stock Performance

Shares of Towa Pharmaceutical stock opened at $25.33 on Thursday. Towa Pharmaceutical has a 52-week low of $16.83 and a 52-week high of $25.33. The company has a 50 day moving average of $25.33 and a 200 day moving average of $25.33.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.